Metformin-Associated Lactic Acidosis Undergoing Renal Replacement Therapy in Intensive Care Units: A Five-Million Population-Based Study in the North-West of Italy

Blood Purif. 2017;44(3):198-205. doi: 10.1159/000471917. Epub 2017 Jul 1.

Abstract

Background: Metformin-associated lactic acidosis (MALA) is a severe complication of drug administration with significant morbidity and mortality. So far no study in large population areas have examined the incidence, clinical profile and outcome of acute kidney injury (AKI)-MALA patients admitted in intensive care units (ICUs) and treated by renal replacement therapy (MALA-RRT).

Methods: Retrospective analysis over a 6-year period (2010-2015) in Piedmont and Aosta Valley regions (5,305,940 inhabitants, 141,174 diabetics treated with metformin) of all MALA-RRT cases.

Results: One hundred and seventeen cases of AKI-MALA-RRT were observed (12.04/100,000 metformin treated diabetics, 1.45% of all RRT-ICU patients). Survival rate was 78.3%. The average duration of RRT was 4.0 days at mean dialysis effluent of 977 mL/kg/day. At admission most patients were dehydrated, and experienced shock and oliguria.

Conclusion: Our data showed that MALA-RRT is a common complication, needing more prevention. Adopted policy of early, extended, continuous and high efficiency dialysis could contribute to an observed high survival rate. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=471917.

Keywords: Acute kidney injury; Epidemiology; Intensive care units; Lactic acidosis; Metformin; Renal replacement therapy; Survival.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Acidosis, Lactic* / chemically induced
  • Acidosis, Lactic* / epidemiology
  • Acidosis, Lactic* / therapy
  • Aged
  • Critical Care*
  • Female
  • Humans
  • Intensive Care Units*
  • Italy
  • Male
  • Metformin / administration & dosage
  • Metformin / adverse effects*
  • Renal Replacement Therapy*
  • Retrospective Studies

Substances

  • Metformin